Xingnaojing mPEG2000-PLA modified microemulsion for transnasal delivery: pharmacokinetic and brain-targeting evaluation.
Xingnaojing microemulsion (XNJ-M) administered intranasally is used for stroke treatment. In order to decrease the XNJ-M-induced mucosal irritation, XNJ-M modified by mPEG2000-PLA (XNJ-MM) were prepared in a previous work. The present work aimed to assess the impact of mPEG2000-PLA on pharmacokinetic features and brain-targeting ability of XNJ-M. The bioavailability and brain-target effects of borneol and geniposide in XNJ-M and XNJ-MM were compared in mice after intravenous (i.v.) and intranasal (i.n.) administrations. Gas chromatography, high-performance liquid chromatography, and ultra-performance liquid chromatography/tandem mass spectrometry methods were developed for the quantification of borneol and geniposide. Blood and brain samples were collected from mice at different time points after i.v. and i.n. treatments with borneol at 8.0 mg/kg, geniposide at 4.12 mg/kg. In addition, near-infrared fluorescence dye, 1,1'-dioctadecyl-3,3,3',3'-tetramethyl indotricarbocyanine iodide was loaded into microemulsions to evaluate the brain-targeting ability of XNJ-M and XNJ-MM by near-infrared fluorescence imaging in vivo and ex vivo. For XNJ-M and XNJ-MM, the relative brain targeted coefficients (Re) were 134.59% and 198.09% (borneol), 89.70% and 188.33% (geniposide), respectively. Besides, significant near-infrared fluorescent signal was detected in the brain after i.n. administration of microemulsions, compared with that of groups for i.v. administration. These findings indicated that mPEG2000-PLA modified microemulsion improved drug entry into blood and brain compared with normal microemulsion: the introduction of mPEG2000-PLA in microemulsion resulted in brain-targeting enhancement of both fat-soluble and water-soluble drugs. These findings provide a basis for the significance of mPEG2000-PLA addition in microemulsion, defining its effects on the drugs in microemulsion.
a School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , China.
Ran
R
Wen
a School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , China.
Qing
Q
Zhang
a School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , China.
Pan
P
Xu
a School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , China.
Jie
J
Bai
a School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , China.
Pengyue
P
Li
a School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , China.
Shouying
S
Du
a School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , China.
Yang
Y
Lu
D000281:Administration, Intranasal; D000818:Animals; D001682:Biological Availability; D001921:Brain / Q000187:drug effects*; D001892:Camphanes / Q000737:chemistry; D016503:Drug Delivery Systems; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D004655:Emulsions / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D039823:Iridoids / Q000737:chemistry; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009296:Nasal Cavity / Q000378:metabolism*; D011091:Polyesters / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry*; D020521:Stroke / Q000188:drug therapy
D001892:Camphanes; D004365:Drugs, Chinese Herbal; D004655:Emulsions; D039823:Iridoids; D011091:Polyesters; C000594497:xingnaojing; C007835:geniposide; D011092:Polyethylene Glycols; C033616:poly(lactide); C022871:isoborneol
Borneol; Xingnaojing; geniposide; mPEG2000-PLA; microemulsion; pharmacokinetics